In a cell line derived from a patient-derived tumor xenograft (PDX) of mesenchymal GBM (PDXM), a set of TGFβ signaling-associated miRNAs was identified after LY2109761 (a TβRI/II inhibitor)18 treatment by transcriptomic sequencing. This evidence concerns the gene TGFBR1 and glioblastoma.